Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,480
Closed -$319K 75
2023
Q2
$319K Buy
+2,480
New +$300K 0.2% 65
2023
Q1
Sell
-70
Closed -$7.93K 94
2022
Q4
$7.93K Hold
70
0.01% 116
2022
Q3
$6K Buy
+70
New +$5.93K ﹤0.01% 125

Other funds holding DXCM

WD Rutherford's DXCM Position: Q3 2023 in Review

WD Rutherford sold out of DexCom (DXCM) in Q3 2023, closing a stake of 2,480 shares — an estimated $319K sold.

WD Rutherford first reported a position in DXCM in Q3 2022 and held it in 3 quarters. The position peaked at $319K in Q2 2023. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • WD Rutherford reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • WD Rutherford sold 2,480 DexCom shares in Q3 2023, an estimated $319K.
  • WD Rutherford first reported a position in DexCom in Q3 2022 and held it in 3 quarters.
  • WD Rutherford's DexCom position peaked at $319K in Q2 2023.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on WD Rutherford's 13F filing for Q3 2023, filed 24 Oct 2023.